Abstract:The human body is home to a variety of micro-organisms. Most of these microbial communities reside in the gut and are referred to as gut microbiota. Over the last decades, compelling evidence showed that a number of human pathologies are associated with microbiota dysbiosis, thereby suggesting that the reinstatement of physiological microflora balance and composition might ameliorate the clinical symptoms. Among possible microbiota-targeted interventions, pre/pro-biotics supplementations were shown to provide effective results, but the main limitation remains in the limited microbial species available as probiotics. Differently, fecal microbiota transplantation involves the transplantation of a solution of fecal matter from a donor into the intestinal tract of a recipient in order to directly change the recipient's gut microbial composition aiming to confer a health benefit. Firstly used in the 4th century in traditional Chinese medicine, nowadays, it has been exploited so far to treat recurrent Clostridioides difficile infections, but accumulating data coming from a number of clinical trials clearly indicate that fecal microbiota transplantation may also carry the therapeutic potential for a number of other conditions ranging from gastrointestinal to liver diseases, from cancer to inflammatory, infectious, autoimmune diseases and brain disorders, obesity, and metabolic syndrome. In this review, we will summarize the commonly used preparation and delivery methods, comprehensively review the evidence obtained in clinical trials in different human conditions and discuss the variability in the results and the pivotal importance of donor selection. The final aim is to stimulate discussion and open new therapeutic perspectives among experts in the use of fecal microbiota transplantation not only in Clostridioides difficile infection but as one of the first strategies to be used to ameliorate a number of human conditions.

The Role of Fecal Microbiota Transplantation (FMT) in the Management of Metabolic Diseases in Humans: A Narrative Review

Fecal Microbiota Transplantation: a Future Therapeutic Option for Obesity/Diabetes?

Impact of Fecal Microbiota Transplantation on Obesity and Metabolic Syndrome—A Systematic Review

Fecal microbiota transplantation in the metabolic diseases: Current status and perspectives

Fecal Microbiota Transplantation for Weight and Glycemic Control of Obesity as Well as the Associated Metabolic Diseases: Meta-Analysis and Comprehensive Assessment

Fecal microbiota transplantation in metabolic syndrome: History, present and future

Fecal microbiota transplantation in obesity metabolism: a META analysis and systematic review

Gut microbiota and obesity: implications for fecal microbiota transplantation therapy

Possibilities of Autologous Fecal Microbiota Transplantation in patients with obesity and diabetes mellitus

Fecal microbiota transplantation as novel therapy in gastroenterology: A systematic review

Fecal microbiota transplantation: current challenges and future landscapes

Fecal Microbiota Transplantation as New Therapeutic Avenue for Human Diseases

Fecal microbiota transplantation for the treatment of intestinal and extra‐intestinal diseases: Mechanism basis, clinical application, and potential prospect

Fecal microbiota transplantation in the obesity treatment – a literature review

Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook

Fecal Microbiota Transplantation and Other Gut Microbiota Manipulation Strategies

The gut microbiome dysbiosis and regulation by fecal microbiota transplantation: umbrella review

Fecal microbiota transplant as a new therapeutic in the management of type 2 Diabetes Mellitus

Fecal microbiota transplantation: in perspective

Application and development of fecal microbiota transplantation in the treatment of gastrointestinal and metabolic diseases: A review

Fecal Microbiota Transplantation Broadening Its Application Beyond Intestinal Disorders.